A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components.
about
Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagenInduced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stressPlatelet-derived NO slows thrombus growth on a collagen type III surfacePrimary arrest of circulating platelets on collagen involves phosphorylation of Syk, cortactin and focal adhesion kinase: studies under flow conditionsRagged spiking of free calcium in ADP-stimulated human platelets: regulation of puff-like calcium signals in vitro and ex vivoA mouse model of severe von Willebrand disease: defects in hemostasis and thrombosisHigh-speed platelet adhesion under conditions of rapid flow.Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood.Poly(ethylmethacrylate-co-diethylaminoethyl acrylate) coating improves endothelial re-population, bio-mechanical and anti-thrombogenic properties of decellularized carotid arteries for blood vessel replacement.von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.Increased platelet deposition on atherosclerotic coronary arteriesPlatelet von Willebrand factor in inherited and acquired bleeding disordersEndothelial cell behaviour within a microfluidic mimic of the flow channels of a modular tissue engineered constructFinite platelet size could be responsible for platelet margination effect.Mechanobiology of platelets: techniques to study the role of fluid flow and platelet retraction forces at the micro- and nano-scale.Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathwaysMicrofluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.Platelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein Ibα.Atherosclerosis and thrombosis: insights from large animal models.Microvascular platforms for the study of platelet-vessel wall interactions.Shear stress responses of adult blood outgrowth endothelial cells seeded on bioartificial tissue.The impact of blood shear rate on arterial thrombus formation.Utility of microfluidic devices to study the platelet-endothelium interface.Flow chamber and microfluidic approaches for measuring thrombus formation in genetic bleeding disorders.Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.von Willebrand factor binds to native collagen VI primarily via its A1 domain.The development of an in-vitro perfusion system for studies on cultured cells.The seeding of human aortic endothelial cells on the extra-cellular matrix of human umbilical vein endothelial cells.Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets.Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow.Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues.Platelets Drive Thrombus Propagation in a Hematocrit and Glycoprotein VI-Dependent Manner in an In Vitro Venous Thrombosis Model.Live-cell Imaging of Platelet Degranulation and Secretion Under Flow.Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests.
P2860
Q24292860-A3DE02D2-E576-41CE-A506-7D6E099C573EQ24795387-F8CA3C28-05B7-4FD3-9E92-980F45C76E75Q24800867-D1884E4A-2BE8-48C9-B796-72A7C5DC583AQ28192915-64DDE699-9486-4ED9-9441-358B65E46A6BQ28354009-45E27920-DE07-4BF2-86A8-538BEFF0E8DDQ28586884-4C20D291-F1E9-4204-B73C-98E1EF34D510Q30438797-A7BFE26E-EC76-4F94-95DE-B8E72AA53ABFQ30495037-9D18F288-EE71-48CB-A161-7AD39F13A8DFQ30847463-B7006255-D40B-4076-8C2E-075BFBCF03FBQ33858605-695FB4EC-99BF-4F38-A6EF-D0C338DDA752Q34112433-8524C0BE-4817-4EC0-AE27-A90CF25599AAQ34125013-6457D873-9062-45EF-ACCA-9EEE93A65B8CQ34466557-758A42CD-76D8-40F4-80AF-6E60F336F0F3Q34577987-D1067CC7-ED94-45A3-B934-034D84B57970Q35342189-6E3D0449-CBAD-4712-B538-0B6AA322AA7FQ35669517-2869198A-4AD1-4FCD-B960-6EBD09A76154Q35882061-CABFDA21-B644-40DC-B050-9D7ACA5944C5Q37012522-EA1E6D4C-9B70-4D62-8346-D257D5BD62ECQ37273226-5584AA2D-7064-450C-A7FC-1C4AD22AFE3FQ37832958-648BF1DD-B8F7-45C0-98AD-92ED2BCAA909Q38179566-B51DAFF3-8145-43E3-99CE-CBB8F6AE8118Q38556612-21E29601-0E96-4DA2-BBDB-0CCFA25FFD3FQ38776937-F3A0A3B2-1784-4C1E-AF5E-2C737E9798F8Q39208821-A1CFCB37-01FE-45D3-A526-51E6EF3A04BCQ39322760-F684AE32-3462-474E-BD16-9612A88AA5F4Q40340403-4859034D-5A78-4099-879C-240B289F9FEEQ40918338-D348EB32-CC56-45BB-B74D-2A91E7F97E87Q41110213-D877EF2F-999B-4DB0-B984-4FC4D0D9F4BDQ41156838-D99B8F68-FEE4-4CB2-ABFC-F3820B0C7765Q41168162-BB5EADDD-AD05-49A1-86A7-C46235F7C09EQ41519363-5603BE29-B3AA-43A3-A44A-27ECAA351C7CQ42728181-786A0A0B-0777-479E-98D1-C8EC85C07AB0Q42827719-07A6E17B-2AC8-4A08-80FE-239639335BE9Q50146003-F447CB9A-242F-4FED-96CA-981338C7B912Q50527610-8EDE29F9-22B0-4E70-9764-DB9F814757F8Q52571175-C353E320-C254-4BAF-819B-2F992AE8A2E6
P2860
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
A perfusion chamber developed ...... trix, and purified components.
@ast
A perfusion chamber developed ...... trix, and purified components.
@en
type
label
A perfusion chamber developed ...... trix, and purified components.
@ast
A perfusion chamber developed ...... trix, and purified components.
@en
prefLabel
A perfusion chamber developed ...... trix, and purified components.
@ast
A perfusion chamber developed ...... trix, and purified components.
@en
P2093
P1476
A perfusion chamber developed ...... trix, and purified components.
@en
P2093
Houdijk WP
Sakariassen KS
de Groot PG
P304
P577
1983-10-01T00:00:00Z